We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information for patients, public and health care professionals.
Guidance for hospitals, tissue establishments and fertility clinics for ensuring the quality and safety of human organs, tissues and cells (including reproductive cells).
Essential elements for implementation of the family origin questionnaire (FOQ) to help assess if a person is a likely carrier for sickle cell and thalassaemia (SCT).
A complete list of 5G projects involved in the 5G Testbeds and Trials Programme
Automation is the future for manufacturing stem cells, says the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell Bank (UKSCB) on its 20th Anniversary.
Advice for people who commission, fund, deliver and evaluate health outreach programmes.
Information on the programme, including the screening tests, commissioning, quality assurance, education and training.
Findings from a 2021 to 2022 incident response by the UK Health Security Agency (UKHSA) to Staphylococcus capitis in UK neonatal units.
Population screening programmes: NHS sickle cell and thalassaemia (SCT) screening programme. The latest pages tagged as SCT will appear here.
The Open Networks Research and Development (R&D) Fund is the £250 million government supported programme to deliver upon the UK’s 5G Supply Chain Diversification Strategy.
Projects granted during 2014 that have a primary purpose of other basic research: sensory organs (skin, eyes and ears), forensic enquiries and other research.
These documents list sickle cell and thalassaemia high and low prevalence NHS Trusts in England and explain how prevalence is determined.
Forms for sickle cell and thalassaemia (SCT) screening laboratories to send antenatal data to the national programme.
A collection of the annual reports for Sickle cell and thalassaemia screening (SCT) standards from 2021/22 inclusive.
Leaflet for expectant fathers explaining antenatal screening for sickle cell and thalassaemia.
Information for healthcare professionals, patients, and the public.
Data reports, data collection templates and research application guidance for the NHS sickle cell and thalassaemia (SCT) screening programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).